Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on the proposed modification of action regarding Chinese exports under Section 301.
Click here for the full comments.
Related Posts
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA E&C Letter on Improving Competition in the Generic Marketplace
April 1, 2019
Dear Chairman Pallone and Ranking Member Walden, I am writing to you on behalf...
HSCA Releases Third Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
March 24, 2020
Washington, DC (March 24, 2020) – The Healthcare Supply Chain Association (HSCA),...
HSCA Submits Comments to ANSI on Healthcare Supply Chain Data Standards to Help Improve Accuracy, Efficiency, and Patient Safety
November 26, 2019
Washington, DC (November 26, 2019) – The Healthcare Supply Chain Association...